The efficacy and tolerability of duloxetine for the treatment of panic disorder
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2013
At a glance
- Drugs Duloxetine (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- 21 Jul 2011 Actual end date (January 2009) added as reported by ClinicalTrials.gov.
- 21 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Apr 2007 New trial record.